Sanofi lands 3rd Covid-19 vac­cine man­u­fac­tur­ing part­ner as it works to push for­ward its own jab

As the de­mand for mR­NA-based Covid-19 vac­cines per­sists, Sanofi is jump­ing in­to the fray.

The French drug­mak­er has en­tered an agree­ment with Mod­er­na to man­u­fac­ture the com­pa­ny’s Covid-19 vac­cine. The agree­ment marks the third dif­fer­ent com­pa­ny Sanofi has paired with to man­u­fac­ture a Covid-19 vac­cine, since their own ef­fort to de­vel­op a pan­dem­ic in­oc­u­la­tion faced sig­nif­i­cant set­backs.

The com­pa­ny will per­form fill-and-fin­ish at its Ridge­field, NJ site to com­plete up to 200 mil­lion dos­es of the vac­cine. That will be­gin in Sep­tem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER